Clinical Validation of a Multipurpose Assay for Detection and Genotyping ofCALRMutations in Myeloproliferative Neoplasms

Rapid and sensitive detection of CALR exon 9 mutations using high-resolution melting analysis

(2015) Ken-Hong Lim et al.   CLINICA CHIMICA ACTA

Evaluation of methods to detect CALR mutations in myeloproliferative neoplasms

(2015) Amy V. Jones et al.   LEUKEMIA RESEARCH

Calreticulin Exon 9 Mutations in Myeloproliferative Neoplasms

(2015) Jung-Sook Ha et al.   Annals of Laboratory Medicine

CALRmutations in myeloproliferative neoplasms: Hidden behind the reticulum

(2014) Paola Guglielmelli et al.   AMERICAN JOURNAL OF HEMATOLOGY

Discriminating between essential thrombocythemia and masked polycythemia vera inJAK2mutated patients

(2014) Tiziano Barbui et al.   AMERICAN JOURNAL OF HEMATOLOGY

Type 1 versus Type 2 calreticulin mutations in essential thrombocythemia: A collaborative study of 1027 patients

(2014) Ayalew Tefferi et al.   AMERICAN JOURNAL OF HEMATOLOGY

CALRmutation studies in chronic neutrophilic leukemia

(2014) Terra L. Lasho et al.   AMERICAN JOURNAL OF HEMATOLOGY

Calreticulin mutations in myeloproliferative neoplasms and new methodology for their detection and monitoring

(2014) Jianxiang Chi et al.   ANNALS OF HEMATOLOGY

Atypical chronic myeloid leukemia is clinically distinct from unclassifiable myelodysplastic/myeloproliferative neoplasms

(2014) S. A. Wang et al.   BLOOD

Integrated genomic analysis illustrates the central role of JAK-STAT pathway activation in myeloproliferative neoplasm pathogenesis

(2014) R. Rampal et al.   BLOOD

Clonal evolution and clinical correlates of somatic mutations in myeloproliferative neoplasms

(2014) P. Lundberg et al.   BLOOD

From Janus kinase 2 to calreticulin: the clinically relevant genomic landscape of myeloproliferative neoplasms

(2014) M. Cazzola et al.   BLOOD

Mutations and thrombosis in essential thrombocythemia: prognostic interaction with age and thrombosis history

(2014) Naseema Gangat et al.   EUROPEAN JOURNAL OF HAEMATOLOGY

CALR and ASXL1 mutations-based molecular prognostication in primary myelofibrosis: an international study of 570 patients

(2014) A Tefferi et al.   LEUKEMIA

CALR vs JAK2 vs MPL-mutated or triple-negative myelofibrosis: clinical, cytogenetic and molecular comparisons

(2014) A Tefferi et al.   LEUKEMIA

Bioinformatic analyses of CALR mutations in myeloproliferative neoplasms support a role in signaling

(2014) L Eder-Azanza et al.   LEUKEMIA

An overview on CALR and CSF3R mutations and a proposal for revision of WHO diagnostic criteria for myeloproliferative neoplasms

(2014) A Tefferi et al.   LEUKEMIA

CALR mutations and a new diagnostic algorithm for MPN

(2014) Ayalew Tefferi et al.   Nature Reviews Clinical Oncology

CALRmutations are rare in childhood essential thrombocythemia

(2014) Stephen E. Langabeer et al.   PEDIATRIC BLOOD & CANCER

High Resolution Melting Analysis: A Rapid and Accurate Method to Detect CALR Mutations

(2014) Cristina Bilbao-Sieyro et al.   PLoS One

Impact of calreticulin mutations on clinical and hematological phenotype and outcome in essential thrombocythemia

(2013) G. Rotunno et al.   BLOOD

JAK2 or CALR mutation status defines subtypes of essential thrombocythemia with substantially different clinical course and outcomes

(2013) E. Rumi et al.   BLOOD

Calreticulin gene exon 9 frameshift mutations in patients with thrombocytosis

(2013) J Chi et al.   LEUKEMIA

Somatic CALR Mutations in Myeloproliferative Neoplasms with Nonmutated JAK2

(2013) J. Nangalia et al.   NEW ENGLAND JOURNAL OF MEDICINE

Somatic Mutations of Calreticulin in Myeloproliferative Neoplasms

(2013) Thorsten Klampfl et al.   NEW ENGLAND JOURNAL OF MEDICINE